Remove 2008 Remove FDA Remove Licensing Remove Public Health
article thumbnail

HHS Recommends Re-Classification of Marijuana as a Schedule III Controlled Substance – A Bellwether for the Future of Cannabis-ness

Health Law Advisor

The HHS recommendation is predicated, via the FDA, on a scientific and medical evaluation of marijuana, using a statutorily required eight-factor analysis. This effectively allows the DEA to adopt a different outcome than the FDA. The agencies rarely disagree on final scheduling placement. heroin, LSD, and ecstasy).

FDA 111
article thumbnail

States and Feds Signal Big Changes to Telehealth Prescribing

Health Law Advisor

In the era of abortion regulation and the wind-down of the COVID-19 public health emergency (“PHE”), new legislation in states such as Utah may be a sign of what is to come for online and telehealth prescribing. The bill currently awaits Governor Spencer Cox’s signature and would take effect sixty (60) days after its signing. [1]

article thumbnail

Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives

Healthcare Law Blog

Effective January 1, 2022, an individual in Oregon who acts as a pharmaceutical representative for more than 15 days during the calendar year must have, and renew annually, a license from the Department of Consumer and Business Services (“DCBS”). ix] Nevada. xi] Washington D.C.